BioCorRx (BICX) Total Liabilities (2010 - 2026)

BioCorRx (BICX) has 17 years of Total Liabilities data on file, last reported at $13.9 million in Q1 2026.

• Quarterly Total Liabilities fell 25.02% year-over-year to $13.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.9 million (down 25.02% YoY) and the FY2025 annual result came in at $13.7 million, up 7.32% from the prior year.
• Total Liabilities rose to $13.9 million in Q1 2026 per BICX's latest filing, from $13.7 million in the prior quarter.
• The five-year high for Total Liabilities was $20.3 million in Q3 2025, with the low at $7.9 million in Q1 2022.
• Average Total Liabilities over 5 years is $12.2 million, with a median of $11.2 million recorded in 2024.
• Year-over-year, Total Liabilities surged 69.4% in 2025 and slipped 25.02% in 2026.
• BioCorRx's Total Liabilities stood at $9.0 million in 2022, then rose by 15.31% to $10.3 million in 2023, then advanced by 23.21% to $12.7 million in 2024, then rose by 7.32% to $13.7 million in 2025, then rose by 2.0% to $13.9 million in 2026.
• Business Quant data shows BICX's Total Liabilities at $13.9 million in Q1 2026, $13.7 million in Q4 2025, and $20.3 million in Q3 2025.